Sign In
Last checked at 
27 Nov 2020 07:00
27 November 2020
Eurocell plc
Director/PDMR Shareholding
Eurocell plc (the "Company") announces that, on 25 November 2020:
· options granted on 4 April 2017 under the Eurocell plc Deferred Share Plan 2015, to acquire ordinary shares in the Company, were exercised by 2 directors; and
· shares acquired, as a result of the above exercise, were sold by 2 directors to cover the associated tax and national insurance liabilities
The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | A - Mark Kelly B - Michael Scott | ||||
2. | Reason for the notification | |||||
a) | Position / status | A - Chief Executive Officer B - Chief Financial Officer | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Eurocell plc | ||||
b) | Legal Entity Identifier | 213800RH62IQ7S9OFQ55 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | ||||
b) | Nature of the transaction | Exercise of nil-cost options to acquire ordinary shares under the Eurocell plc Deferred Share Plan 2015 | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total |
N/A - single transactions | ||||
e) | Date of the transaction | 25 November 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | A - Mark Kelly B - Michael Scott | ||||
2. | Reason for the notification | |||||
a) | Position / status | A - Chief Executive Officer B - Chief Financial Officer | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Eurocell plc | ||||
b) | Legal Entity Identifier | 213800RH62IQ7S9OFQ55 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | ||||
b) | Nature of the transaction | Sale of ordinary shares, acquired under the Eurocell plc Deferred Share Plan 2015, to cover the associated tax and national insurance liabilities | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Aggregated price - Aggregated total |
N/A - single transactions | ||||
e) | Date of the transaction | 25 November 2020 | ||||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
For further information:
Eurocell plc 01773 842 100
Paul Walker
Group Company Secretary
Follow the stocks
